{"filing":{"accession_number":"0001213900-26-073184","cik":"0001359931","ticker":"TARA","company_name":"Protara Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"ea0296286-8k_protara.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1359931/000121390026073184/ea0296286-8k_protara.htm"},"events":[{"id":14727,"run_id":13119,"accession_number":"0001213900-26-073184","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Leonardo Viana Nicacio, M.D., the Company's Chief Medical Officer, resigned effective June 26, 2026 to explore other opportunities. This is a clear departure of a named executive officer. While the filing notes that his duties will be assumed by existing personnel (Carla Beckham and oversight by Jacqueline Zummo), the principal disclosed action is the resignation of a C-suite executive, making this an exec_departure event.","company_name":"Protara Therapeutics, Inc.","ticker":"TARA","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":12243,"accession_number":"0001213900-26-073184","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Leonardo Viana Nicacio, M.D., the Company's Chief Medical Officer, resigned effective June 26, 2026 to explore other opportunities. This is a clear departure of a named executive officer. While the filing notes that his duties will be assumed by existing personnel (Carla Beckham and oversight by Jacqueline Zummo), the principal disclosed action is the resignation of a C-suite executive, making this an exec_departure event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T21:03:42.582917+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12243,"accession_number":"0001213900-26-073184","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Leonardo Viana Nicacio, M.D., the Company's Chief Medical Officer, resigned effective June 26, 2026 to explore other opportunities. This is a clear departure of a named executive officer. While the filing notes that his duties will be assumed by existing personnel (Carla Beckham and oversight by Jacqueline Zummo), the principal disclosed action is the resignation of a C-suite executive, making this an exec_departure event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T21:03:42.582917+00:00","company_name":"Protara Therapeutics, Inc.","ticker":"TARA","filing_date":"2026-06-29"}]}